GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OTCPK:NVZMY) » Definitions » Float Percentage Of Total Shares Outstanding

NVZMY (Novonesis (Novozymes) B) Float Percentage Of Total Shares Outstanding : 0.00% (As of Mar. 31, 2025)


View and export this data going back to 2009. Start your Free Trial

What is Novonesis (Novozymes) B Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Novonesis (Novozymes) B's float shares is 0.00 Mil. Novonesis (Novozymes) B's total shares outstanding is 464.36 Mil. Novonesis (Novozymes) B's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Novonesis (Novozymes) B's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Novonesis (Novozymes) B's Institutional Ownership is 0.01%.


Novonesis (Novozymes) B Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Novonesis (Novozymes) B's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/464.36
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novonesis (Novozymes) B Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OTCPK:NVZMY) » Definitions » Float Percentage Of Total Shares Outstanding
Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

From GuruFocus

Q1 2023 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2021 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2020 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novonesis AS's Dividend Analysis

By GuruFocus Research 04-30-2024

Q3 2020 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Half Year 2024 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 08-29-2024

Novozymes A/S Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024